Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Minutes of annual general meeting
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Carsten Trads, Chairman, comments on the Rights Issue
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Notice of extraordinary general meeting
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S intends to resolve on a partially (77 percent) guaranteed rights issue of approximately DKK 28.5 million
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q2-2022 report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S signs supply agreement with WEECO Pharma GmbH worth DKK 40 million
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: According to a recent opinion poll a majority of Danes are positive towards legalization of cannabis
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S postpones quarterly report for Q2 2022